Synthesis of racemic cis-5-hydroxy-3-phthalimidoglutarimide. A metabolite of thalidomide isolated from human plasma

Frederick A. Luzzio*, Damien Y. Duveau, Erin R. Lepper, William D. Figg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

A synthesis of the glutarimide-derived metabolite of thalidomide, 5′-hydroxythalidomide (2), is described. The synthesis employed the lactone derivative of N-benzyloxycarbonyl (CBZ)-protected 4-hydroxyglutamic acid 12, which is prepared by a de novo route from diethyl acetamidomalonate. The reaction of 12 with 4-methoxybenzylamine gave the corresponding isoglutamine, which then provided the key CBZ-protected N-PMB-glutarimide 14 after dehydration. Deprotection of both the CBZ and PMB groups followed by phthalimidation and deacetylation of the 3-amino-5-acetoxyglutarimide 16 afforded 2.

Original languageEnglish
Pages (from-to)10117-10120
Number of pages4
JournalJournal of Organic Chemistry
Volume70
Issue number24
DOIs
StatePublished - 25 Nov 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synthesis of racemic cis-5-hydroxy-3-phthalimidoglutarimide. A metabolite of thalidomide isolated from human plasma'. Together they form a unique fingerprint.

Cite this